(NaturalNews) Recently, scientists took a huge leap forward in developing a radically new form of immunization. Researchers from the Scripps Research Institute reported in February that they had successfully used a new form of gene therapy to induce monkeys to produce an antibody that deactivates HIV.
This new therapy is fundamentally different from vaccination, which consists of introducing small amounts of infectious material into the body to induce it to produce its own antibodies. In immunoprophylaxis by gene transfer (IGT), scientists instead hope to modify the DNA of patients to enable them to produce entirely new antibodies.
“The reality is we are touching third rails, and so it’s going to take some explanation,” said David Baltimore of the California Institute of Technology, a Nobel Prize recipient, virologist and IGT researcher. Continue reading